You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Filter by group:
Filter by availability:
Displaying drugs 76 - 100 of 2019 in total
DrugBank ID Name Weight StructureCategoriesTherapeutic Indication
DB09323
1538-09-6
Benzathine benzylpenicillin909.13

C48H56N6O8S2
ThumbAmides / Anti-Bacterial Agents / Anti-Infective Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Aza Compounds / Azabicyclo Compounds / Beta-Lactam Antibacterials, Penicillins / Beta-Lactamase Sensitive Penicillins / Bicyclo Compounds / Bicyclo Compounds, Heterocyclic / Bridged Compounds / Heterocyclic Compounds / Heterocyclic Compounds, 1-Ring / Heterocyclic Compounds, 2-Ring / Heterocyclic Compounds, Bridged-Ring / Hydrocarbons / Hydrocarbons, Cyclic / Inorganic Chemicals / Lactams / Organic Chemicals / Penicillin G / Penicillins / Polycyclic Compounds / Sulfur Compounds / beta-LactamsNot Annotated
DB05630
16037-91-5
Sodium stibogluconate907.88

C12H35Na3O26Sb2
ThumbAcids, Acyclic / Agents Against Leishmaniasis and Trypanosomiasis / Anthelmintics / Anti-Infective Agents / Antimony Compounds / Antiparasitic Agents / Antiparasitic Products, Insecticides and Repellents / Antiplatyhelmintic Agents / Antiprotozoals / Carbohydrates / Carboxylic Acids / Gluconates / Hydroxy Acids / Organic Chemicals / Organometallic Compounds / Schistosomicides / Sugar AcidsFor the treatment of various types of a protozoal infection called leishmaniasis, which may result from sandfly bites in tropical and temperate par...
DB09160
127455-27-0
Technetium Tc-99m tetrofosmin898.86

C36H84O10P4Tc
ThumbCardiovascular System / Diagnostic Radiopharmaceuticals / Technetium (99Mtc) CompoundsNot Annotated
DB09296
1258226-87-7
Ombitasvir894.127

C50H67N7O8
ThumbAcids, Acyclic / Amides / Antiinfectives for Systemic Use / Antiviral Agents / Antivirals for Systemic Use / Carboxylic Acids / Cytochrome P-450 CYP2C8 Substrates / Direct Acting Antivirals / Organic Chemicals / P-glycoprotein/ABCB1 SubstratesWhen used within the fixed dose combination product of paritaprevir/ombitasvir/ritonavir (Technivie), ombitasvir is indicated in combination with r...
DB00483
65-29-2
Gallamine Triethiodide891.5291

C30H60I3N3O3
ThumbAmines / Ammonium Compounds / Cholinergic Agents / Cholinergic Antagonists / Cholinesterase Inhibitors / Inorganic Chemicals / Neuromuscular Agents / Neuromuscular Blocking Agents / Neuromuscular Nondepolarizing Agents / Neurotransmitter Agents / Nicotinic Antagonists / Nitrogen Compounds / Onium Compounds / Organic Chemicals / Peripheral Nervous System Agents / Quaternary Ammonium CompoundsFor use as adjuncts to anesthesia to induce skeletal muscle relaxation and to facilitate the management of patients undergoing mechanical ventilation
DB09027
1256388-51-8
Ledipasvir888.9999

C49H54F2N8O6
ThumbAnti-Infective Agents / Antiinfectives for Systemic Use / Antiviral Agents / Antivirals for Systemic Use / Direct Acting Antivirals / Heterocyclic Compounds / Heterocyclic Compounds, 2-Ring / Hydrocarbons / Hydrocarbons, Aromatic / Hydrocarbons, Cyclic / Organic Chemicals / Polycyclic Compounds / Polycyclic Hydrocarbons, AromaticLedipasvir in combination with sofosbuvir, or in combination with sofosbuvir and ribavirin, is indicated for the treatment of chronic hepatitis C (...
DB11613
1377049-84-7
Velpatasvir883.019

C49H54N8O8
ThumbAcids, Acyclic / Carboxylic Acids / Heterocyclic Compounds / Organic ChemicalsUsed together with sofosbuvir in the treatment of hepatitis C infection of all six major genotypes.
DB11574
1370468-36-2
Elbasvir882.035

C49H55N9O7
ThumbAzoles / BCRP/ABCG2 Inhibitors / Heterocyclic Compounds / Heterocyclic Compounds, 1-Ring / Heterocyclic Compounds, 2-Ring / P-glycoprotein/ABCB1 InhibitorsElbasvir, when used in combination with grazoprevir as the combination product Zepatier, is indicated for use with or without ribavirin for the tr...
DB01201
61379-65-5
Rifapentine877.0307

C47H64N4O12
ThumbAmides / Anti-Bacterial Agents / Anti-Infective Agents / Antibiotics, Antitubercular / Antiinfectives for Systemic Use / Antimycobacterials / Antitubercular Agents / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strong) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strong) / Cytochrome P-450 CYP2D6 Inducers / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A4 Inducers (strong) / Drugs for Treatment of Tuberculosis / Heterocyclic Compounds / Heterocyclic Compounds with 4 or More Rings / Heterocyclic Compounds, 1-Ring / Lactams / Lactams, Macrocyclic / Leprostatic Agents / Macrocyclic Compounds / Organic Chemicals / Polycyclic Compounds / RifamycinsFor the treatment of pulmonary tuberculosis.
DB11581
1257044-40-8
Venetoclax868.45

C45H50ClN7O7S
ThumbAmides / BCRP/ABCG2 Substrates / Bicyclo Compounds / Bridged Compounds / Cytochrome P-450 CYP3A4 Substrates / Heterocyclic Compounds / Heterocyclic Compounds, 2-Ring / Heterocyclic Compounds, Bridged-Ring / Hydrocarbons / Hydrocarbons, Cyclic / Inorganic Chemicals / Organic Chemicals / P-glycoprotein/ABCB1 Substrates / Polycyclic Compounds / Sulfones / Sulfur CompoundsFor the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at ...
DB09146
8047-67-4
Iron saccharate866.546

C12H29Fe5Na2O23
ThumbAcids, Acyclic / Anemia, Iron-Deficiency / Antianemic Preparations / Blood and Blood Forming Organs / Carbohydrates / Carboxylic Acids / Disaccharides / Drugs for Treatment of Hyperkalemia and Hyperphosphatemia / Hematinics / Hematologic Agents / Hydroxy Acids / Inorganic Chemicals / Iron Compounds / Iron Preparations / Iron Salts / Iron Trivalent, Oral Preparations / Oligosaccharides / Organic Chemicals / Organometallic Compounds / Pharmaceutical Preparations / Polysaccharides / Sugar AcidsNot Annotated
DB06783
14038-43-8
Prussian blue859.239

C18Fe7N18
ThumbAcids / Acids, Noncarboxylic / Anions / Antidotes / Coloring Agents / Cyanides / Electrolytes / Ferrous Compounds / Hydrogen Cyanide / Inorganic Chemicals / Ions / Iron Compounds / Nitrogen Compounds / Organic Chemicals / Organometallic Compounds / Protective AgentsNot Annotated
DB01229
33069-62-4
Paclitaxel853.9061

C47H51NO14
ThumbAlbumins / Amino Acids, Peptides, and Proteins / Antimitotic Agents / Antineoplastic Agents / Antineoplastic Agents, Phytogenic / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Substrates / BSEP/ABCB11 Inhibitors / CYP3A4 Inducers (Weak) / Combined Inhibitors of CYP3A4 and P-glycoprotein / Cyclodecanes / Cycloparaffins / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Substrates / Diterpenes / Hydrocarbons / Hydrocarbons, Alicyclic / Hydrocarbons, Cyclic / Hypotensive Agents / Immunosuppressive Agents / Macrocyclic Compounds / Mitosis Modulators / Myelosuppressive Agents / Organic Chemicals / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates / Paclitaxel / Polycyclic Compounds / Proteins / Taxane Derivatives / Taxoids / Terpenes / Tubulin ModulatorsUsed in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of meta...
DB00615
72559-06-9
Rifabutin847.0047

C46H62N4O11
ThumbAmides / Anti-Bacterial Agents / Anti-Infective Agents / Antibiotics, Antitubercular / Antiinfectives for Systemic Use / Antimycobacterials / Antitubercular Agents / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A4 Inducers (strong) / Cytochrome P-450 CYP3A4 Substrates / Drugs for Treatment of Tuberculosis / Heterocyclic Compounds / Heterocyclic Compounds with 4 or More Rings / Heterocyclic Compounds, 1-Ring / Lactams / Lactams, Macrocyclic / Macrocyclic Compounds / Organic Chemicals / Polycyclic Compounds / RifamycinsFor the prevention of disseminated <i>Mycobacterium avium</i> complex (MAC) disease in patients with advanced HIV infection.
DB06145
24916-50-5
Spiramycin843.065

C43H74N2O14
ThumbAnti-Bacterial Agents / Anti-Infective Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Antiparasitic Agents / Antiprotozoals / Carbohydrates / Coccidiostats / Cytochrome P-450 CYP3A4 Substrates / Glycosides / Lactones / Leucomycins / Macrocyclic Compounds / Macrolide Antibiotics / Macrolides / Macrolides, Lincosamides and Streptogramins / Organic Chemicals / Polycyclic Compounds / PolyketidesNot Annotated
DB00778
80214-83-1
Roxithromycin837.0465

C41H76N2O15
ThumbAnti-Bacterial Agents / Anti-Infective Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Substrates / Erythromycin / Lactones / Macrocyclic Compounds / Macrolide Antibiotics / Macrolides / Macrolides, Lincosamides and Streptogramins / Organic Chemicals / Polycyclic Compounds / PolyketidesUsed to treat respiratory tract, urinary and soft tissue infections.
DB06772
183133-96-2
Cabazitaxel835.9324

C45H57NO14
ThumbAntineoplastic Agents / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Inhibitors / Cyclodecanes / Cycloparaffins / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A4 Substrates / Diterpenes / Hydrocarbons / Hydrocarbons, Alicyclic / Hydrocarbons, Cyclic / Immunosuppressive Agents / Macrocyclic Compounds / Myelosuppressive Agents / Organic Chemicals / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates / Polycyclic Compounds / Taxane Derivatives / Taxoids / TerpenesFor treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.
DB00954
62013-04-1
Dirithromycin835.086

C42H78N2O14
ThumbAnti-Bacterial Agents / Anti-Infective Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Lactones / Macrocyclic Compounds / Macrolides / Macrolides, Lincosamides and Streptogramins / Organic Chemicals / Polycyclic Compounds / PolyketidesFor the treatment of the following mild-to-moderate infections caused by susceptible strains of microorganisms: acute bacterial exacerbations of ch...
DB01321
16846-24-5
Josamycin827.995

C42H69NO15
ThumbAnti-Bacterial Agents / Anti-Infective Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Cytochrome P-450 CYP3A Inhibitors / Lactones / Macrocyclic Compounds / Macrolide Antibiotics / Macrolides / Macrolides, Lincosamides and Streptogramins / Organic Chemicals / Polycyclic Compounds / PolyketidesFor the treatment of bacterial infections.
DB00541
57-22-7
Vincristine824.9576

C46H56N4O10
ThumbAlkaloids / Antimitotic Agents / Antineoplastic Agents / Antineoplastic Agents, Phytogenic / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Substrates / Combined Inhibitors of CYP3A4 and P-glycoprotein / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Substrates / Heterocyclic Compounds / Heterocyclic Compounds, 2-Ring / Immunosuppressive Agents / Indole Alkaloids / Indoles / Mitosis Modulators / P-glycoprotein/ABCB1 Inducers / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates / Secologanin Tryptamine Alkaloids / Tubulin Modulators / Vinca Alkaloids / Vinca Alkaloids and AnaloguesTreatment of acute lymphocytic leukemia (ALL), Hodgkin lymphoma, non-Hodgkin lymphomas, Wilms' tumor, neuroblastoma, rhabdomyosarcoma. Liposomal vi...
DB01045
13292-46-1
Rifampicin822.9402

C43H58N4O12
ThumbAmides / Anti-Bacterial Agents / Anti-Infective Agents / Antibiotics, Antitubercular / Antiinfectives for Systemic Use / Antimycobacterials / Antitubercular Agents / BSEP/ABCB11 Inhibitors / CYP1A2 Inducers (Strong) / Chemically-Induced Disorders / Combined Inducers of CYP3A4 and P-glycoprotein / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strong) / Cytochrome P-450 CYP2A6 Inducers / Cytochrome P-450 CYP2A6 Inhibitors / Cytochrome P-450 CYP2A6 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strong) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strong) / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strong) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strong) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2E1 Inducers / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A4 Inducers (strong) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Drugs for Treatment of Tuberculosis / Enzyme Inhibitors / Heterocyclic Compounds / Heterocyclic Compounds with 4 or More Rings / Heterocyclic Compounds, 1-Ring / Lactams / Lactams, Macrocyclic / Leprostatic Agents / Macrocyclic Compounds / Nucleic Acid Synthesis Inhibitors / Organic Chemicals / P-glycoprotein/ABCB1 Inducers / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates / Polycyclic Compounds / RifamycinsFor the treatment of Tuberculosis and Tuberculosis-related mycobacterial infections.
DB01362
66108-95-0
Iohexol821.1379

C19H26I3N3O9
ThumbAcids, Carbocyclic / Benzene Derivatives / Benzoates / Carboxylic Acids / Contrast Media / Diagnostic Uses of Chemicals / Hydrocarbons / Hydrocarbons, Aromatic / Hydrocarbons, Cyclic / Iodinated Contrast Agents / Iodobenzoates / Organic Chemicals / Triiodobenzoic Acids / Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media / X-Ray Contrast Media, IodinatedIohexol ia used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures.
DB01361
2751-09-9
Troleandomycin813.9684

C41H67NO15
ThumbAnti-Bacterial Agents / Anti-Infective Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Combined Inhibitors of CYP3A4 and P-glycoprotein / Cytochrome P-450 CYP2A6 Inhibitors / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Substrates / Lactones / Macrocyclic Compounds / Macrolide Antibiotics / Macrolides / Macrolides, Lincosamides and Streptogramins / Oleandomycin / Organic Chemicals / P-glycoprotein/ABCB1 Inhibitors / Polycyclic Compounds / PolyketidesFor the treatment of Pneumococcal pneumonia due to susceptible strains and group A beta-hemolytic streptococcal infections of the upper respiratory...
DB00976
191114-48-4
Telithromycin812.018

C43H65N5O10
ThumbAnti-Bacterial Agents / Anti-Infective Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strong) / Cytochrome P-450 CYP3A4 Substrates / Erythromycin / Ketolides / Lactones / Macrocyclic Compounds / Macrolide Antibiotics / Macrolides / Macrolides, Lincosamides and Streptogramins / Moderate Risk QTc-Prolonging Agents / Organic Chemicals / Polycyclic Compounds / Polyketides / Protein Synthesis Inhibitors / RNA, Ribosomal, 23SFor the treatment of <i>Pneumococcal</i> infection, acute sinusitis, acute bacterial tonsillitis, acute bronchitis and bronchiolitis, lower respira...
DB00570
865-21-4
Vinblastine810.9741

C46H58N4O9
ThumbAlkaloids / Antimitotic Agents / Antineoplastic Agents / Antineoplastic Agents, Phytogenic / Antineoplastic and Immunomodulating Agents / BSEP/ABCB11 Inhibitors / CYP2D6 Inhibitors (Weak) / Combined Inhibitors of CYP3A4 and P-glycoprotein / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (weak) / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A4 Substrates / Heterocyclic Compounds / Heterocyclic Compounds, 2-Ring / Immunosuppressive Agents / Indole Alkaloids / Indoles / Mitosis Modulators / Myelosuppressive Agents / OCT2 Substrates / P-glycoprotein/ABCB1 Inducers / P-glycoprotein/ABCB1 Inhibitors / P-glycoprotein/ABCB1 Substrates / Secologanin Tryptamine Alkaloids / Tubulin Modulators / Vinca Alkaloids / Vinca Alkaloids and AnaloguesFor treatment of breast cancer, testicular cancer, lymphomas, neuroblastoma, Hodgkin's and non-Hodgkin's lymphomas, mycosis fungoides, histiocytosi...
Displaying drugs 76 - 100 of 2019 in total